Company record
Lannett Company Inc.
0 FDA warning letters since 2023 and 3 recalls in the last 12 months.
Get an email the day FDA posts anything new about Lannett Company Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jul 8 | Class II | Lannett Company Inc. Drug |
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelph… Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules. |
| Jun 10 | Class II | Lannett Company Inc. Drug |
Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46. Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint. |
| May 27 | Class III | Lannett Company Inc. Drug |
Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1231-01. Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. |